Skip to main content
. 2022 Jul 22;13:864868. doi: 10.3389/fimmu.2022.864868

Table 1.

Antigen-binding domains tested as CAR elements in this study.

Antibody Name Type Target Affinity (K D) Cross-Reactivity Competition Epitope Location Ref
sdAb021 sdAb EGFR (Erbb1) 38.5 nM Human, Cyno Competitive with sdAb027, partial with sdAb028 Unknown, likely domain IV (29)
sdAb027 sdAb EGFR (Erbb1) 1.6 nM Human, Cyno Competitive with sdAb021, partial with sdAb028 Unknown, likely domain IV (29)
sdAb028 sdAb EGFR (Erbb1) 9.0 nM Human, Mouse Partial competition with sdAb021 and sdAb027 Unknown, likely domain IV (29)
Trastuzumab scFv HER2 (Erbb2) n.d. (5 nM) a Human, Cyno Juxtamembrane conformational epitope in domain IV Very membrane proximal (30, 31)
F265 scFv EGFRvIII n.d. (27.5 nM) a Unknown Domain I/III neoepitope, non-competitive with F269 Membrane distal (32) and unpublished
F269 scFv EGFRvIII n.d. (31.5 nM) a Unknown Domain I/III neoepitope of EGFR, non-competitive with F265 Membrane distal (32) and unpublished
a

Binding of scFvs was not evaluated. Monovalent affinity of full-length IgG is shown in parentheses.

Cyno, cynomolgus monkey.